⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

January 1, 2001World Journal of GastroenterologyOpen Access

Expression of insulin like growth factor II and its receptor in hepatocellular carcinogenesis

View Full Paper

Ask AI

Bookmark

Share

Abstract

Subject headings liver neoplasms/pathology; insulin-like growth factor II/biosynthesis; receptors, somatomedin/ biosynthesis; RNA, messenger/biosynthesis; in situ hybridization; hepatitis, chronic/pathology

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Zi Rong Fan (2001) studied this question.

synapsesocial.com/papers/6a8450234e8c7cff228d73b9 https://doi.org/10.3748/wjg.v7.i2.285

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Developmental and tissue-specific expression of a family of transcripts related to rat insulin-like growth factor II mRNAOriginal Research · 1985 · 156 citations
2Regulation of human IGF-II transcription in fetal and adult tissuesOriginal Research · 1987 · 51 citations
3Tissue-Specific and Developmentally Regulated Transcription of the Insulin-Like Growth Factor 2 GeneOriginal Research · 1987 · 160 citations
4Gene therapy of murine teratocarcinoma: separate functions for insulin-like growth factors I and II in immunogenicity and differentiation.Original Research · 1994 · 42 citations
5Actions of Insulin-Like Growth FactorsOriginal Research · 1985 · 1,154 citations

Reactivation of rat insulin-like growth factor II gene during hepatocarcinogenesis1988
Altered body composition and increased frequency of diverse malignancies in insulin-like growth factor-II transgenic mice.1994
Insulinlike growth factor II expression and oval cell proliferation associated with hepatocarcinogenesis in woodchuck hepatitis virus carriers1988
Triglyceride-glucose and body shape index as metabolic-morphometric markers for metabolic dysfunction-associated steatotic liver disease identification across glycemic spectrumWorld Journal of Gastroenterology · 2026
Circadian disruption in metabolic dysfunction-associated steatotic liver disease: From hepatic clock remodeling to chronotherapeutic strategiesWorld Journal of Gastroenterology · 2026

More from World Journal of Gastroenterology